NRSNVSREFR• 28 Days (Normalized)
NRSN vs REFR (NeuroSense Therapeutics Ltd. vs Research Frontiers Incorporated)
Showing Closing Date Range from Sep 3 to Oct 1, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NRSN Performance $4.78
+1089.05%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
REFR Performance $0.74
+%
Research Frontiers Incorporated
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
+1089.05 pts
NRSN outperforming by 1089.05 percentage points
NRSNREFR
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NRSN REFR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | NRSN Price | NRSN Gain (%) | REFR Price | REFR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $4.78 | +1089.05% | $- | - | |
| Sep 28, 2026 | $5.10 | +1168.66% | $- | - | |
| Sep 25, 2026 | $6.95 | +1628.86% | $- | - | |
| Sep 24, 2026 | $7.40 | +1740.80% | $0.74 | +80.66% | +1660.14% |
| Sep 23, 2026 | $7.40 | +1740.80% | $0.71 | +73.17% | +1667.63% |
| Sep 22, 2026 | $7.18 | +1686.07% | $0.78 | +90.24% | +1595.83% |
| Sep 21, 2026 | $6.62 | +1546.77% | $0.76 | +85.37% | +1461.40% |
| Sep 18, 2026 | $6.35 | +1479.60% | $0.65 | +58.54% | +1421.06% |
| Sep 17, 2026 | $6.72 | +1571.64% | $0.39 | -4.88% | +1576.52% |
| Sep 16, 2026 | $6.49 | +1514.43% | $0.38 | -7.32% | +1521.75% |
| Sep 15, 2026 | $7.03 | +1648.76% | $0.36 | -12.20% | +1660.96% |
| Sep 14, 2026 | $6.90 | +1616.42% | $0.38 | -7.32% | +1623.74% |
| Sep 11, 2026 | $0.35 | -13.68% | $0.39 | -4.88% | -8.80% |
| Sep 10, 2026 | $0.33 | -17.41% | $0.39 | -4.88% | -12.53% |
| Sep 09, 2026 | $0.40 | -0.25% | $0.39 | -4.88% | +4.63% |
Page 1 of 2